Product sourcing reference

L-Carnitine

L-Carnitine is an amino-acid derivative with approved pharmaceutical forms. Distinguish a regulated injectable from research material before requesting it.

Reference variants

Add L-Carnitine to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

200mgVial · confirm physical formCAS 541-15-1

$11.21/vialCloseout estimate Regular $22.43. Subject to confirmation; not a stock promise.

Quantity of L-Carnitine 200mg in vials vials, packs of 10

Review your order request · Compare the full catalog

Confirm the exact substance

Levocarnitine has approved uses for specific deficiency states. Material sold for other purposes may not meet the same specification.

What the review will ask

The reference lists a closeout estimate for this item. Treat that figure as subject to confirmation and request a written specification.

State the facility type, destination state and intended transaction. Do not send patient information.
Expect product- and lot-specific documentation to be requested before any material is accepted.
A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Is L-Carnitine an approved drug?

Levocarnitine has FDA-approved products for defined indications. That approval covers those products, not every L-Carnitine material.

Compare the chemical form and product presentation

A levocarnitine medicine and an L-carnitine reference ingredient require different documentation. A shared name or closeout estimate does not establish equivalence to a finished product.

Documentation to request

Ask for chemical identity, concentration or content, manufacturer and product labeling. Check any approval assertion against the specific preparation.

Regulatory context: FDA: compounding, approval and quality standards. Source reviewed 2026-10-16. This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Longevity clinic documentation questions. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements